| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |